Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

AI Assistance for Clinicians Identifying Causes of Chest Pain From ECG Images

12 novembre 2026 aggiornato da: Shenda Hong, Peking University Health Science Center

A Two-Arm Parallel-Group Randomized Trial of ZERO-Assisted and Unassisted Clinicians Identifying Causes of Chest Pain From Real-World ECG Images

This study will assess whether reports generated by ZERO, a mobile system for interpreting electrocardiogram (ECG) images, improve clinicians' ability to identify causes of chest pain compared with interpretation without AI assistance.

A total of 120 licensed cardiology clinicians will be randomly assigned in a 1:1 ratio to ZERO-assisted or unassisted interpretation. Each clinician will assess 30 ECG cases during a single session lasting up to 60 minutes. The cases will include five examples from each of six diagnostic categories: unstable angina, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, aortic dissection, pulmonary embolism, and other diagnoses. No case or patient will be repeated within or across clinicians.

For each case, clinicians will first review the ECG and submit an initial diagnosis that cannot subsequently be changed. Clinicians in the ZERO-assisted group will then view a fixed report generated before clinician randomization. Clinicians in the unassisted group will review the ECG again without an AI report. All clinicians will then submit a final diagnosis.

Diagnostic performance will be assessed against clinical reference diagnoses established before the interpretation task and withheld from participating clinicians. The study will use ECG cases from completed clinical encounters and will not affect patient care. The hypothesis is that ZERO-assisted clinicians will achieve higher final diagnostic accuracy than unassisted clinicians.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

120

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 110 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Licensed cardiology clinicians who routinely participate in the diagnosis or management of chest pain or cardiovascular disease and interpret electrocardiograms (ECGs).
  • Able to read Chinese-language reports and use the study platform.
  • Willing to provide electronic informed consent and sign a confidentiality statement.
  • Willing to complete all 30 assigned ECG interpretation tasks within the specified study period.

Exclusion Criteria:

  • Access to the reference diagnoses of the study cases, or involvement in screening, selecting, or adjudicating these cases.
  • Prior knowledge of the answers to the study cases through participation in model development or previous experiments.
  • Duplicate enrollment.
  • Inability to complete training in the use of the study platform.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Diagnostico
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: No AI Assistance

Clinicians will interpret 30 unique ECG cases, with five cases from each diagnostic category, during a single session lasting up to 60 minutes. For each case, clinicians will review the ECG image and submit an initial first-choice diagnosis, which will then be locked. They will subsequently review the same ECG image again without an AI report and submit a final first-choice diagnosis, which will also be locked.

Sperimentale: ZERO Assistance

Clinicians will first review each assigned ECG image and submit and lock an initial first-choice diagnosis. They will then view the fixed ZERO-generated report and submit and lock a final first-choice diagnosis. The report will include risk alerts for STEMI, aortic dissection, and pulmonary embolism, ranked diagnostic candidates, supporting explanations and available sources, and suggestions for further evaluation. If the report is unavailable or invalid, the failure will be recorded and the clinician may still submit a final diagnosis. Each clinician will complete 30 unique cases, with five cases per diagnostic category.

ZERO is a mobile system that processes de-identified ECG images and generates structured diagnostic reports. It integrates image preprocessing, a dedicated prediction model, risk stratification, knowledge retrieval, and report generation using GLM-4.6. Reports will be generated and stored before clinician randomization using a prespecified, frozen model, prompts, and retrieval configuration. During the interpretation task, the corresponding report will be displayed only after the clinician has submitted and locked the initial diagnosis. No additional patient information or clinician responses will be supplied to the system, and reports will not be modified during the task. No online adaptation will occur during the study.

Altri nomi:
  • ZERO

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Finalfirst-choice diagnostic accuracy
Lasso di tempo: 60 Minutes

For each clinician, final first-choice diagnostic accuracy will be calculated as the number of cases in which the final first-choice diagnosis matches the prespecified clinical reference diagnosis, divided by 30 and multiplied by 100%. Each clinician will assess five cases from each of six diagnostic categories. The outcome will be summarized as the mean clinician-level accuracy in each randomized group. Only clinicians with both an initial and a final diagnosis recorded for all 30 cases will be included in the diagnostic outcome analysis. The primary comparison will be between the ZERO-assisted and unassisted groups.

60 Minutes

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Final Missed-Diagnosis Percentage for ST-Segment Elevation Myocardial Infarction
Lasso di tempo: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of ST-segment elevation myocardial infarction for which the final first-choice diagnosis is not ST-segment elevation myocardial infarction. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Aortic Dissection
Lasso di tempo: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of aortic dissection for which the final first-choice diagnosis is not aortic dissection. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Pulmonary Embolism
Lasso di tempo: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of pulmonary embolism for which the final first-choice diagnosis is not pulmonary embolism. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Proportion of Cases Revised From an Incorrect to a Correct Diagnosis
Lasso di tempo: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis does not match the reference diagnosis but the final first-choice diagnosis does match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Higher values indicate that more cases were corrected during the second assessment.

60 Minutes
Proportion of Cases Revised From a Correct to an Incorrect Diagnosis
Lasso di tempo: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis matches the reference diagnosis but the final first-choice diagnosis does not match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Lower values indicate that fewer initially correct diagnoses became incorrect during the second assessment.

60 Minutes

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

19 novembre 2026

Completamento primario (Stimato)

11 dicembre 2026

Completamento dello studio (Stimato)

18 dicembre 2026

Date di iscrizione allo studio

Primo inviato

12 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • ZERO-RCT26001

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .